Polyrizon completes site contracts for Nasarix allergy trial

Go back to Polyrizon completes site contracts for Nasarix allergy trial
(NASDAQ: PLRZ) Delayed: 10.99 -0.04 (0.36%)
Previous Close $11.03    52 Week High
Open $11.01    52 Week Low
Day High $11.07    P/E N/A 
Day Low $10.36    EPS
Volume 32,056